The Clinical Effects of Manipulative Therapy in People with Chronic Obstructive Pulmonary Disease
Publication: The Journal of Alternative and Complementary Medicine
Volume 24, Issue Number 7
Abstract
Objectives: This study aimed to determine the effects of manipulative therapies (MT), including spinal manipulation, and diaphragmatic release techniques on lung function, exercise capacity, symptoms, and health-related quality of life (HRQOL) in people with chronic obstructive pulmonary disease (COPD).
Design: Systematic review.
Participants: People diagnosed with COPD.
Intervention: Randomized controlled trials of MT (either with or without pulmonary rehabilitation [PR]) compared to other treatments (soft tissue [ST] therapy or sham therapy) applied in people with COPD were identified following the search of seven databases. Two reviewers independently assessed study quality and extracted data.
Outcome measures: Lung function, exercise capacity, symptoms, and HRQOL.
Results: Four studies were included, with a total of 68 participants. The heterogeneity between treatments prevented meta-analysis. There was no beneficial effect on spirometry measures of lung function with MT. MT combined with PR improved exercise capacity by 48–49 m more than ST therapy plus PR. Less dyspnea was reported with MT and ST therapy compared to ST therapy alone (p = 0.01), but there was no effect on HRQOL, or symptoms of anxiety or depression.
Conclusions: In people with COPD, MT (either with or without PR) improved functional exercise capacity, but had no effect on lung function, or HRQOL. Further research is required to determine the underlying mechanism of this treatment approach and its relationship to exercise capacity.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am Respir Crit Care Med 2017;195:557–582.
2.
Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008;3:637–658.
3.
Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging 2006;1:253–260.
4.
Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest 2009;135:173–180.
5.
Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: Underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000;71:1033–1047.
6.
Roberts M, Mapel D, Hartry A, et al. Chronic pain and pain medication use in chronic obstructive pulmonary disease. Ann Am Thorac Soc 2013;10:290–298.
7.
Graat-Verboom EFM, Wouters FWJ, Smeen M, et al. Current status of research on osteoporosis in COPD: A systematic review. Eur Respir J 2009;34:209–218.
8.
Chen Y-W, Camp P, Coxson HO, et al. Comorbidities that cause pain and the contributors to pain in individuals with chronic obstructive pulmonary disease. Arch Phys Med Rehab 2017;98:1535–1543.
9.
Dias D, Kirkwood R, Parreira V, Sampaio R. Orientation and postiion of the scapula, head and kyphosis thoracic in male patients with COPD. Can J Respir Ther 2009;3:30–34.
10.
Pachioni C, Ferrante J, Panissa T, et al. Postural assessment in patients with chronic obstructive pulmonary disease. Fisioterap Pesq 2011;8:34134–34135.
11.
Lee AL, Goldstein RS, Brooks D. Chronic pain in people with chronic obstructive pulmonary disease: Prevalence, clinical and psychological implications. J COPDF 2017;4:194–203.
12.
HajGhanbari B, Holsti L, Road JD, Reid WD. Pain in people with chronic obstructive pulmonary disease (COPD). Respir Med 2012;106:998–1005.
13.
Maltais F, Decramer M, Casaburi R, et al. An Official American Thoracic Society/European Respiratory Society Statement: Update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014;189:e15–e62.
14.
Saey D, Debigare R, LeBlanc P, et al. Contractile leg fatigue after cycle exercise: A factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:425–430.
15.
McCarthy B, Casey D, Davane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015;2:CD003793.
16.
Heneghan NR, Adab P, Balanos G, Jordan RE. Manual therapy for chronic obstructive airways disease: A systematic review of current evidence. Man Ther 2012;17:507–518.
17.
Wearing J, Beaumont S, Forbes D. The use of spinal manipulative therapy in the management of chronic obstructive pulmonary disease: A systematic review. J Altern Complement Med 2016;22:108–114.
18.
Engel R, Vemulpad S, Beath K. Short-term effects of a course of manual therapy and exercise in people with moderate chronic obstructive pulmonary disease: A preliminary clinical trial. J Manipulative Physiol Ther 2013;36:490–496.
19.
Rocha T, Souza H, Brandao DC, et al. The manual diaphragm release technique improves diaphragmatic mobility, inspiratory capacity and exercise capacity in people with chronic obstructive pulmonary disease: A randomised trial. J Physiother 2015;61;182–189.
20.
Moher D, Liberati A, Tetzlaff J, Altman DG; The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009;6:e1000097.
21.
PEDRo scale PEDro. PEDro scale. 1999. Online document at: https://www.pedro.org.au/wp-content/uploads/PEDro_scale.pdf, accessed March 3, 2017.
22.
Maher CG, Sherrington C, Herbert RD, et al. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther 2003;83:713–721.
23.
Armijo-Olivo S, da Costa BR, Cummings GG, et al. PEDro or cochrane to assess the quality of clinical trials? A meta-epidemiological study. PLoS One 2015;10:e0132634.
24.
Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Online document at: www.handbook.cochrane.org, accessed March 3, 2017.
25.
Bown MJ, Sutton AJ. Quality control in systematic reviews and meta-analyses. Eur J Vasc Endovasc Surg 2010;40:669–677.
26.
Decision Support Systems. Statistical Power Calculators, Researchers Toolkit. 2017. Online document at: https://www.dssresearch.com/KnowledgeCenter/toolkitcalculators/statisticalpowercalculators.aspx, accessed March 7, 2017.
27.
Engel RM, Gonski P, Beath K, Vemulpad S. Medium term effects of including manual therapy in a pulmonary rehabilitation program for chronic obstructive pulmonary disease (COPD): A randomized controlled pilot trial. J Man Manipulative Ther 2016;24:80–89.
28.
Zanotti E, Berardinelli P, Bizzarri C, et al. Osteopathic manipulative treatment effectiveness in severe chronic obstructive pulmonary disease: A pilot study. Complement Ther Med 2012;20:16–22.
29.
Singh SJ, Puhan MA, Andrianopoulos V, et al. An Official Systematic Review of the European Respiratory Society/American Thoracic Society: Measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 2014;44:1447–1478.
30.
Shin DC, Lee YW. The immediate ffects of spinal thoracic manipulation on respiratory functions. J Phys Ther Sci 2016;28:2547–2549.
31.
Wall BA, Peiffer JJ, Losco B, Hebert JJ. The effect of manual therapy on pulmonary function in healthy adults. Sci Rep 2016;6:33244.
32.
Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948–968.
33.
Engel RM, Vemulpad S. The effect of combining manual therapy with exercise on the respiratory function of normal individuals: A randomized control trial. J Manipulative Physiol Ther 2007;30:509–513.
34.
Noll DR, Johnson JC, Baer RW, Snider EJ. The immediate effect of individual manipulation techniques on pulmonary function measures in persons with chronic obstructive pulmonary disease. Osteopath Med Prim Care 2009;3:9.
35.
Shavelle RM, Paculdo DR, Kush SJ, et al. Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up Study. Int J Chron Obstruct Pulmon Dis 2009;4:137–148.
36.
Karanicolas PJ, Farrokhyar F, Bhandari M. Blinding: Who, what, when, why, how? Can J Surg 2010;53:345–348.
Information & Authors
Information
Published In
The Journal of Alternative and Complementary Medicine
Volume 24 • Issue Number 7 • July 2018
Pages: 677 - 683
PubMed: 29595991
Copyright
Copyright 2018, Mary Ann Liebert, Inc.
History
Published in print: July 2018
Published online: 1 July 2018
Published ahead of print: 29 March 2018
Topics
Authors
Author Disclosure Statement
No competing financial interests exist.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.